"Chemokine CCL11" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC-type chemokine that is specific for CCR3 RECEPTORS. It is a potent chemoattractant for EOSINOPHILS.
| Descriptor ID |
D054413
|
| MeSH Number(s) |
D12.644.276.374.200.110.550 D12.776.467.374.200.110.550 D23.125.300.110.550 D23.469.200.110.550 D23.529.374.200.110.550
|
| Concept/Terms |
Chemokine CCL11- Chemokine CCL11
- CCL11, Chemokine
- Small Chemokine (C-C Motif) Ligand 11
- Eotaxin-1
- Eotaxin 1
- CCL11 Chemokine
- Chemokine, CCL11
- Chemokine (C-C Motif) Ligand 11
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL11".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL11".
This graph shows the total number of publications written about "Chemokine CCL11" by people in this website by year, and whether "Chemokine CCL11" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL11" by people in Profiles.
-
Epidermal expression of eotaxins and thymic stromal lymphopoietin in eosinophil rich dermatoses. Arch Dermatol Res. 2019 Nov; 311(9):705-710.
-
Mechanisms of pathogenic effects of eosinophil cationic protein and eosinophil-derived neurotoxin on human keratinocytes. Exp Dermatol. 2018 12; 27(12):1322-1327.
-
Induction of Adaptive Immunity Leads to Nigrostriatal Disease Progression in MPTP Mouse Model of Parkinson's Disease. J Immunol. 2017 06 01; 198(11):4312-4326.
-
Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients. Laryngoscope. 2017 10; 127(10):2210-2218.
-
Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease. J Biol Chem. 2016 07 15; 291(29):15267-81.
-
Attenuation of microglial RANTES by NEMO-binding domain peptide inhibits the infiltration of CD8(+) T cells in the nigra of hemiparkinsonian monkey. Neuroscience. 2015 Aug 27; 302:36-46.